Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FJA5A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,159
Award facts
- Contract value 100% obligated
- $25,158.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,158.51 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on November 20, 2025, with completion targeted for December 12, 2025. IMFINZI is an oncology pharmaceutical used in cancer treatment. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical.
This delivery order falls under AmerisourceBergen's existing $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad range of medications and medical commodities to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs. The Pharmaceutical Prime Vendor Global Program Generation V contract vehicle under which this IDC operates is structured to support multiple contractors across separate regions, enabling flexible fulfillment of diverse pharmaceutical procurement requirements across the military's global healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FJA5A?
SPE2DR26FJA5A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FJA5A worth?
The government has obligated $25,159 on SPE2DR26FJA5A.
Is contract SPE2DR26FJA5A an order under another contract?
Yes. SPE2DR26FJA5A is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJA5A competed?
The extent of competition for SPE2DR26FJA5A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award